Fimo Health
Fimo Health GmbH is a German digital health startup that builds a certified medical device app combining disease-specific education, symptom tracking, and behavioral change support for patients with chronic illnesses experiencing fatigue. The app covers eight indications including Long Covid, ME/CFS, MS, and Cancer, and is distributed via health insurance reimbursement and direct consumer channels in Germany.
- Company typePrivate
- Founded2021
- HeadquartersKöln, Germany
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Fimo Health does
Fimo Health GmbH is a German digital health startup founded in 2021 and headquartered in Bonn that develops the Fimo Health App, a certified medical device designed as an everyday companion for patients with chronic illnesses experiencing fatigue. The app combines disease-specific psychoeducation with systematic symptom and behavior tracking on a modular platform architecture, with content drawn from medical S-guidelines and supplemented with cognitive behavioral therapy and behavioral change science elements. As of 2024, the app offers eight indication-specific modules covering Long Covid, Multiple Sclerosis, Chronic Fatigue Syndrome (ME/CFS), Cancer, Rheumatoid Arthritis, Fibromyalgia, Ulcerative Colitis, and Crohn's Disease, plus a Hybrid Care Program for fatigue management and a Research App solution for clinical studies.
The technology stack centers on a three-pillar "Learn-Act-Track" concept (Konzept) that integrates disease-specific learning content, symptom diary and tracking (with wearables integration for vital data such as heart rate, oxygen saturation, steps, and temperature), and actionable behavioral interventions. The platform holds ISO 27001 information security certification and operates under GDPR with data stored on EU-based servers. An AI-supported fatigue diagnostics capability is being developed through the FAITH research project (November 2023 to October 2025), funded with approximately 760,000 euros by the state of North Rhine-Westphalia, in partnership with University Medical Center Essen, Forschungszentrum Jülich, and Fraunhofer IMS, targeting personalized fatigue scoring and intervention recommendations for tumor-associated fatigue syndrome.
Fimo Health operates a multi-channel GTM combining product-led growth (freemium app distributed via Apple App Store and Google Play) with sales-led B2B partnerships. Revenue streams include: (i) health insurance reimbursement via direct partnerships with 10 German Krankenkassen (including IKK Classic, SBK, Barmenia, AOK Rheinland-Pfalz/Saarland); (ii) self-pay premium subscriptions; (iii) B2B enterprise licensing for corporate health management (BGM) programs; (iv) industrial partnerships; and (v) research institution contracts. The company received undisclosed seed funding in June 2022 from LUMO Labs and Barmenia Next Strategies and has approximately 12 employees.
Fimo Health firmographics
Firmographics- Name
- Fimo Health
- Legal name
- Fimo Health GmbH
- Website
- https://fimohealth.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Fimo Health GmbH is a German digital health startup that builds a certified medical device app combining disease-specific education, symptom tracking, and behavioral change support for patients with chronic illnesses experiencing fatigue. The app covers eight indications including Long Covid, ME/CFS, MS, and Cancer, and is distributed via health insurance reimbursement and direct consumer channels in Germany.
- Ownership category
- akta.pro rank
Fimo Health industry classification
Industry- Product category
- Digital Therapeutics / Digital Health App
- NAICS
- Home Health Care Services (62161)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industries
- Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE), Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI)
Keywords
Where Fimo Health is headquartered
LocationHeadquarters
- HQ city
- Köln
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Fimo Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- Health Insurance Reimbursement: Premium version of the app is reimbursed by partner health insurance companies for their insured members. The app is not a 'Prescription App' (DiGA) but works through direct partnerships with individual health insurers.
- Premium App Subscription: Premium version with full functionality available for self-pay by users whose insurance does not partner with Fimo Health.
- B2B Corporate Health Solutions: Enterprise licensing of the app platform for corporate health management (BGM) programs targeting employees with chronic conditions.
- Research Institution Partnerships: Digital solutions for researchers including the Fimo Health App or a Research App to digitally accompany study participants and gain real-world data.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free base version with selected learning content and symptom tracking |
| Subscription | Annual | Premium/Full version - reimbursed by partner health insurers |
| Subscription | Monthly | FibroCoach special offer - first month free |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Fimo Health product offering
Product offeringCore offering
Fimo Health develops and operates a certified medical device mobile app that combines disease-specific psychoeducation, symptom and behavior tracking (with wearables integration), and behavioral interventions based on cognitive behavioral therapy for patients suffering from chronic fatigue and chronic illnesses. The modular platform supports eight indications (Long Covid, ME/CFS, Multiple Sclerosis, Cancer, Rheumatoid Arthritis, Fibromyalgia, Ulcerative Colitis, Crohn's disease) and is offered as a free base version with a premium version reimbursed by partner health insurers.
Product overview
Fimo Health offers a modular digital health platform centered on the Fimo Health App, which combines disease-specific education with symptom tracking to help chronic disease patients become proactive health managers. The core app provides foundational learning, symptom tracking, and behavioral support features. Disease-specific modules (Long Covid, Multiple Sclerosis, ME/CFS, Cancer, Rheumatoid Arthritis, Fibromyalgia, Ulcerative Colitis, Crohn's Disease) attach to the core platform, each providing tailored content. The company also offers a hybrid care program for comprehensive fatigue management, a research app solution for clinical studies, and tiered access through free basic and premium versions. All modules are built on a modular infrastructure designed for efficient expansion to new indication areas.
Differentiator
Problem solved
Functional benefit
Products and services
- Fimo Health App Certified medical device mobile app combining disease-specific psychoeducation with symptom and behavior tracking to help patients with chronic fatigue-related illnesses regain control and improve quality of life. Available free with a premium version reimbursed by partner health insurers.
- Fimo Health App - Long Covid Module Disease-specific module providing psychoeducation and symptom tracking for Long Covid patients experiencing fatigue and related symptoms.
- Fimo Health App - Multiple Sclerosis Module Disease-specific module providing psychoeducation and symptom tracking for Multiple Sclerosis patients managing fatigue.
- Fimo Health App - Chronic Fatigue Syndrome (ME/CFS) Module Disease-specific module providing psychoeducation and symptom tracking for patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome.
- Fimo Health App - Cancer Module Disease-specific module providing psychoeducation and symptom tracking for cancer patients, particularly addressing tumor-associated fatigue.
- Fimo Health App - Rheumatoid Arthritis Module Disease-specific module providing psychoeducation and symptom tracking for Rheumatoid Arthritis patients managing fatigue.
- Fimo Health App - Fibromyalgia Module Disease-specific module providing psychoeducation and symptom tracking for Fibromyalgia patients managing fatigue and chronic pain.
- Fimo Health App - Ulcerative Colitis Module Disease-specific module providing psychoeducation and symptom tracking for Ulcerative Colitis patients managing fatigue.
- Fimo Health App - Crohn's Disease Module Disease-specific module providing psychoeducation and symptom tracking for Crohn's Disease patients managing fatigue.
- Hybrid Care Program (Fatigue) Comprehensive hybrid care program combining digital app support with healthcare provider coordination for fatigue management in Long Covid, ME/CFS, MS, and Cancer patients.
- Research App Solution Digital companion solution for research projects and clinical studies, enabling participant follow-up and real-world data collection on the Fimo Health platform.
Quantifiable outcome
- Patient empowerment and quality of life improvement for chronic illness patients
- +2 more outcomes
Companies that use Fimo Health
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles4 records
Fimo Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
Fimo Health partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- University Medical Center EssencoreLeading German university hospital contributing palliative care expertise to the FAITH project for AI-supported fatigue therapy. Dr. Mitra Tewes from the palliative care department serves as project contact.
- Jülich Research Center (Forschungszentrum Jülich)coreInstitute of Neuroscience and Medicine contributes biomarker development expertise to the FAITH project. Professor Dr. Jürgen Dukart leads the palliative medicine research institute's involvement.
- Fraunhofer Institute for Microelectronics Circuits and Systems (IMS)coreResearch partner contributing expertise in microelectronics and health technology to the FAITH project. Prof. Karsten Seidl and Caroline Ressing lead the institute's involvement in developing AI-supported fatigue diagnostics.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Fimo Health competitors and assessment
Company assessmentDirect peers
- Selfapy: Selfapy is a Berlin-based digital therapeutics company offering psychologist-led online programs for mental health and chronic conditions, with German statutory insurer reimbursement. Closely comparable business model and German market focus to Fimo Health.
- HelloBetter: HelloBetter (formerly GET.ON) is a German digital therapeutics company offering evidence-based online courses for mental and behavioral health conditions, with DiGA-listed products reimbursed by statutory health insurers. Comparable as a German digital therapeutic with payer coverage.
- Kaia Health: Kaia Health is a digital therapeutics company offering app-based programs for chronic pain and musculoskeletal conditions, with similar payer-reimbursement and B2B GTM. Directly comparable to Fimo Health's chronic-condition digital coaching and tracking model.
- aidhere: aidhere is a German digital therapeutics startup offering the DiGA zanadio for obesity, combining behavioral change, tracking, and coaching. Highly comparable business model (condition-specific coaching + tracking + insurer reimbursement) to Fimo Health.
- Caspar Health: Caspar Health is a Berlin-based digital rehabilitation platform offering app-based therapy programs for post-acute and chronic conditions with German insurer and clinic partnerships. Directly comparable to Fimo Health's chronic-condition rehab/coaching approach.
- Vivira Health Lab: Vivira offers a DiGA-listed digital therapeutic for back pain combining exercise, education, and tracking. Comparable as a German condition-specific digital therapeutic with statutory insurer reimbursement.
Broad incumbents
- Wellster Healthtech: Wellster Healthtech is a Munich-based healthtech platform operating multiple direct-to-consumer health brands across indications. Comparable as a German consumer digital health operator, though broader in scope than Fimo's focused chronic-fatigue positioning.
- Temedica: Temedica is a Munich-based digital health company offering broader patient-journey and real-world-data platforms across multiple conditions. Comparable as a German digital health player, but operates a wider portfolio rather than specializing in fatigue coaching.
Emerging players
- Sidekick Health: Sidekick Health is a Nordic digital therapeutics platform offering app-based lifestyle and chronic-condition management programs with pharma and payer partnerships. Partial overlap with Fimo's chronic-condition coaching and tracking approach.
- Oviva: Oviva is a European digital health company offering app-based nutritional therapy and coaching for chronic metabolic conditions with statutory insurer reimbursement in Germany and other markets. Partial overlap with Fimo's coaching/tracking/insurer model.
Market position
Strengths1 record
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Fimo Health social profiles
Digital presenceFimo Health compliance and trust
Trust signalCompliance3 records
Fimo Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fimo Health leadership team
Management profileNumber of profiles
Profiles12 records
Fimo Health funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fimo Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fimo Health
What does Fimo Health do?
Fimo Health develops and operates a certified medical device mobile app that combines disease-specific psychoeducation, symptom and behavior tracking (with wearables integration), and behavioral interventions based on cognitive behavioral therapy for patients suffering from chronic fatigue and chronic illnesses. The modular platform supports eight indications (Long Covid, ME/CFS, Multiple Sclerosis, Cancer, Rheumatoid Arthritis, Fibromyalgia, Ulcerative Colitis, Crohn's disease) and is offered as a free base version with a premium version reimbursed by partner health insurers.
Is Fimo Health a public or private company?
Fimo Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Fimo Health founded?
Fimo Health was founded in 2021. It employs 11 to 50 people.
Where is Fimo Health based?
Fimo Health is headquartered in Köln, Germany, in the Europe region.
How does Fimo Health make money?
Four revenue lines are on record. Health Insurance Reimbursement is the primary driver. The others are premium App Subscription, B2B Corporate Health Solutions and research Institution Partnerships.
Who are Fimo Health's main competitors?
Direct peers on record are Selfapy, HelloBetter, Kaia Health, aidhere, Caspar Health and Vivira Health Lab. Broad incumbents are Wellster Healthtech and Temedica. Emerging players are Sidekick Health and Oviva.
Does Fimo Health have an API?
No public API is recorded for Fimo Health.
What industry is Fimo Health in?
Fimo Health's product category is Digital Therapeutics / Digital Health App. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALACAE, Chronic Condition Virtual Care & Disease Management (Payer-Sponsored). Its NAICS code is 62161 and its SIC code is 3845.